News

Deal Announcements

NeurAxon Raises Venture Debt Financing

Monday, January 4, 2010 5:54:00 AM PDT | VentureDeal Staff
Toronto, Canada  --  Pharmaceutical company NeurAxon has secured $8.75 million in a new round of venture capital debt funding.

NeurAxon is developing new pain therapeutics aimed at the inhibition of neuronal nitric oxide synthase (nNOS).

Investors in the company include Delphi Ventures, Ventures West, HIG Ventures and BDC Venture Capital.  The company said it would use the funding proceeds to support its ongoing research and development efforts.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1